Approaches to the pharmaceutical industry competitiveness formation

The substantive aspects of the existing mechanisms for the formation and strengthening of competitiveness of domestic pharmaceutical manufacturers are considered. The analysis of various approaches aimed at forming the competitiveness of an industrial enterprise engaged in the development, testing, production and sale of various types of medicines and other types of pharmaceutical products is carried out. The existing body of theoretical knowledge published over the past few years, devoted to the sectoral aspects of the formation of competitiveness of enterprises in various sectors of the national economy, is investigated; the systematization is carried out and the results are presented. The most significant approaches to the formation of enterprise competitiveness are systematized; the interpretation of the concept of an approach to the formation of enterprise competitiveness is proposed; Groups of mechanisms for increasing the competitiveness of modern pharmaceutical manufacturers are identified: domestic, market and marketing, cooperation and partnership, lobbying, innovation and digitalization. It is concluded that today one of the most promising groups of mechanisms used by pharmaceutical manufacturers are those based on the achievements of information and digital technologies (artificial intelligence, neural networks, digital modeling of living organisms, etc.). Taking into account the emerging trends, it can be argued that the ability of modern domestic manufacturers of medicines to form and maintain their competitive positions largely depends on the level of development of innovative information and digital technologies, their degree of proficiency, as well as the ability to independently develop such technologies. The information base of the research is current publications of reputable scientists in the problem area under consideration, opinions of leading experts, analytical publications of various news agencies and news feeds.